Anika Therapeutics
ANIK
158 hedge funds and large institutions have $539M invested in Anika Therapeutics in 2016 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 57 increasing their positions, 59 reducing their positions, and 19 closing their positions.
75.25% more ownership
Funds ownership: 0% → 75.25% (+75%)
36% more call options, than puts
Call options by funds: $1.08M | Put options by funds: $796K
1% more capital invested
Capital invested by funds: $532M → $539M (+$7.21M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 59
3% less funds holding
Funds holding: 163 → 158 (-5)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$16M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.34M |
| 3 |
NAP
New Amsterdam Partners
New York
|
+$2.57M |
| 4 |
Bank of New York Mellon
New York
|
+$2.49M |
| 5 |
JP Morgan Chase
New York
|
+$1.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$8.19M |
| 2 |
Millennium Management
New York
|
-$6.91M |
| 3 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$4.4M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.41M |
| 5 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$2.4M |
ANIK Hedge Fund Activity: Q4 2016 in Review
158 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q4 2016, worth a combined $539M — up 1.4% from $532M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of ANIK and 16 opened new positions — a net loss of 3 holders — while 59 trimmed existing stakes and 57 added.
The largest buyer was Kayne Anderson Rudnick Investment Management, adding an estimated $16M. The largest seller was Numeric Investors, exiting entirely with an estimated $8.19M sold.
- 158 institutional investors held Anika Therapeutics (ANIK) as of Q4 2016, down from 163 in Q3 2016.
- Funds reported $539M of Anika Therapeutics stock for Q4 2016, up 1.4% quarter-over-quarter.
- 16 funds opened new Anika Therapeutics positions in Q4 2016 and 19 closed out, a net change of -3 holders.
- The largest Anika Therapeutics buyer in Q4 2016 was Kayne Anderson Rudnick Investment Management, an estimated $16M added.
- The largest Anika Therapeutics seller in Q4 2016 was Numeric Investors, an estimated $8.19M sold.
Based on aggregated 13F filings for Q4 2016.